Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
+11,000
New +$1.06M ﹤0.01% 2806
2026
Q1
Sell
-5,900
Closed -$595K 3859
2025
Q4
$595K Sell
5,900
-3,800
-39% -$413K ﹤0.01% 3154
2025
Q3
$1.2M Sell
9,700
-19,200
-66% -$2.38M ﹤0.01% 1633
2025
Q2
$3.47M Buy
28,900
+300
+1% +$40K 0.01% 1100
2025
Q1
$4.21M Buy
28,600
+27,100
+1,807% +$4.14M 0.01% 989
2024
Q4
$244K Hold
1,500
﹤0.01% 1844
2024
Q3
$244K Hold
1,500
﹤0.01% 1748
2024
Q2
$205K Hold
1,500
﹤0.01% 1610
2024
Q1
$230K Buy
+1,500
New +$224K ﹤0.01% 1864
2023
Q2
Sell
-5,300
Closed -$839K 2244
2023
Q1
$839K Sell
5,300
-60,000
-92% -$9M ﹤0.01% 1130
2022
Q4
$9.16M Buy
65,300
+60,000
+1,132% +$8.52M 0.03% 578
2022
Q3
$680K Buy
+5,300
New +$765K ﹤0.01% 1125

Other funds holding CLX

Steven Cohen's CLX Position: Q2 2026 in Review

Steven Cohen sold out of Clorox (CLX) in Q2 2026, closing a stake of 1,592,288 shares — an estimated $153M sold.

Steven Cohen first reported a position in CLX in Q2 2017 and held it in 11 quarters. The position peaked at $179M in Q1 2024. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Steven Cohen reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 1,592,288 Clorox shares in Q2 2026, an estimated $153M.
  • Steven Cohen first reported a position in Clorox in Q2 2017 and held it in 11 quarters.
  • Steven Cohen's Clorox position peaked at $179M in Q1 2024.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.